Evidence map›Paper›PMID 42075088›Full record

ArticleNutrients2026

Preparation and Characterization of Rice Bran Protein Hydrolysates Enhanced via Alcalase and

Guanlong Li, Xiaolan Liu, Peng Li, Quanxin Wang, Changyuan Wang, Xiqun Zheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Nutrients, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Guanlong LiHeilongjiang Provincial Key Laboratory of Corn Deep Processing Theory and Technology, College of Food and Bioengineering, Qiqihar University, Qiqihar 161006, China.ORCID 0000-0002-0027-0831
Xiaolan LiuHeilongjiang Provincial Key Laboratory of Corn Deep Processing Theory and Technology, College of Food and Bioengineering, Qiqihar University, Qiqihar 161006, China.
Peng LiHeilongjiang Provincial Key Laboratory of Corn Deep Processing Theory and Technology, College of Food and Bioengineering, Qiqihar University, Qiqihar 161006, China.
Quanxin WangHeilongjiang Provincial Key Laboratory of Corn Deep Processing Theory and Technology, College of Food and Bioengineering, Qiqihar University, Qiqihar 161006, China.
Changyuan WangCollege of Food Science, Heilongjiang Bayi Agricultural University, Daqing 163319, China.
Xiqun ZhengCollege of Food Science, Heilongjiang Bayi Agricultural University, Daqing 163319, China.

Funding

Ministry of Science and Technology of the People's Republic of China 2021YFD2100902
6 · The paper itself

Abstract

backgroundUlcerative colitis, a chronic inflammatory disorder of the intestine, represents a major health concern worldwide. This study aimed to explore the in vivo efficacy of rice bran protein hydrolysates in mitigating UC.

methodsRice bran protein hydrolysates with enhanced antioxidant activity were prepared via co-treatment with Alcalase and

resultsCompared with hydrolysates obtained using Alcalase in isolation (RHP), the co-treated rice bran (CRB) protein hydrolysates exhibited significantly higher antioxidant capacity. Structural characterization revealed marked alterations in molecular weight distribution, amino acid composition, and RHP spectral features, based on Fourier transform infrared spectroscopy, during fermentation with

conclusionsThus, CRB exhibits promising prophylactic effects against ulcerative colitis, suggesting its potential for therapeutic application.

Indexed as

AntioxidantsColitis, UlcerativeLactiplantibacillus plantarumOryzaProtein HydrolysatesSubtilisinsAnimalsColonDisease Models, AnimalMaleMiceOxidative StressAntioxidantsProtein HydrolysatesSubtilisinsintestinal barrier functionLactiplantibacillus plantarum 13110rice bran protein hydrolysatesulcerative colitis

Identifiers

PMID42075088
PMCPMC13118473

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.